Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B
Identifieur interne : 000025 ( PascalFrancis/Curation ); précédent : 000024; suivant : 000026Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B
Auteurs : Aziz Alami Chentoufi [États-Unis] ; Nicholas R. Binder [États-Unis] ; Noureddine Berka [Canada] ; Guillaume Durand [France] ; Alex Nguyen [États-Unis] ; Ilham Bettahi [États-Unis] ; Bernard Maillere [France] ; Lbachir Benmohamed [États-Unis]Source :
- Journal of virology [ 0022-538X ] ; 2008.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Abstract
The identification of "asymptomatic" (i.e., protective) epitopes recognized by T cells from herpes simplex virus (HSV)-seropositive healthy individuals is a prerequisite for an effective vaccine. Using the PepScan epitope mapping strategy, a library of 179 potential peptide epitopes (15-mers overlapping by 10 amino acids) was identified from HSV type 1 (HSV-1) glycoprotein B (gB), an antigen that induces protective immunity in both animal models and humans. Eighteen groups (G1 to G18) of 10 adjacent peptides each were first screened for T-cell antigenicity in 38 HSV-1-seropositive but HSV-2-seronegative individuals. Individual peptides within the two immunodominant groups (i.e., G4 and G14) were further screened with T cells from HLA-DR-genotyped and clinically defined symptomatic (n = 10) and asymptomatic (n = 10) HSV-1-seropositive healthy individuals. Peptides gB161-175 and gB166-180 within G4 and gB661-675 within G14 recalled the strongest HLA-DR-dependent CD4+ T-cell proliferation and gamma interferon production. gB166-180, gB661-675, and gB666-680 elicited ex vivo CD4+ cytotoxic T cells (CTLs) that lysed autologous HSV-1- and vaccinia virus (expressing gB)-infected lymphoblastoid cell lines. Interestingly, gB166-180 and gB666-680 peptide epitopes were strongly recognized by CD4+ T cells from 10 of 10 asymptomatic patients but not by CD4+ T cells from 10 of 10 symptomatic patients (P < 0.0001; analysis of variance posttest). Inversely, CD4+ T cells from symptomatic patients preferentially recognized gB661-675 (P < 0.0001). Thus, we identified three previously unrecognized CD4+ CTL peptide epitopes in HSV-1 gB. Among these, gB166-180 and gB666-680 appear to be "asymptomatic" peptide epitopes and therefore should be considered in the design of future herpes vaccines.
| pA |
|
|---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000069
Links to Exploration step
Pascal:09-0013229Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B</title><author><name sortKey="Alami Chentoufi, Aziz" sort="Alami Chentoufi, Aziz" uniqKey="Alami Chentoufi A" first="Aziz" last="Alami Chentoufi">Aziz Alami Chentoufi</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1><s2>Irvine, California 92697-4375</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Binder, Nicholas R" sort="Binder, Nicholas R" uniqKey="Binder N" first="Nicholas R." last="Binder">Nicholas R. Binder</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1><s2>Irvine, California 92697-4375</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Berka, Noureddine" sort="Berka, Noureddine" uniqKey="Berka N" first="Noureddine" last="Berka">Noureddine Berka</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Tissue Typing Laboratory</s1><s2>Calgary, Alberta T2L2K8</s2><s3>CAN</s3><sZ>3 aut.</sZ></inist:fA14><country>Canada</country></affiliation></author><author><name sortKey="Durand, Guillaume" sort="Durand, Guillaume" uniqKey="Durand G" first="Guillaume" last="Durand">Guillaume Durand</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>CEA, iBiTecS, Service d'Ingenierie Moléculaire des Protéines (SIMOPRO)</s1><s2>Gif Sur Yvette 91191</s2><s3>FRA</s3><sZ>4 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>France</country></affiliation></author><author><name sortKey="Nguyen, Alex" sort="Nguyen, Alex" uniqKey="Nguyen A" first="Alex" last="Nguyen">Alex Nguyen</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1><s2>Irvine, California 92697-4375</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Bettahi, Ilham" sort="Bettahi, Ilham" uniqKey="Bettahi I" first="Ilham" last="Bettahi">Ilham Bettahi</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1><s2>Irvine, California 92697-4375</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Maillere, Bernard" sort="Maillere, Bernard" uniqKey="Maillere B" first="Bernard" last="Maillere">Bernard Maillere</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>CEA, iBiTecS, Service d'Ingenierie Moléculaire des Protéines (SIMOPRO)</s1><s2>Gif Sur Yvette 91191</s2><s3>FRA</s3><sZ>4 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>France</country></affiliation></author><author><name sortKey="Benmohamed, Lbachir" sort="Benmohamed, Lbachir" uniqKey="Benmohamed L" first="Lbachir" last="Benmohamed">Lbachir Benmohamed</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1><s2>Irvine, California 92697-4375</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Center for Immunology, University of California Irvine</s1><s2>Irvine, California 92697-1450</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">09-0013229</idno><date when="2008">2008</date><idno type="stanalyst">PASCAL 09-0013229 INIST</idno><idno type="RBID">Pascal:09-0013229</idno><idno type="wicri:Area/PascalFrancis/Corpus">000069</idno><idno type="wicri:Area/PascalFrancis/Curation">000025</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B</title><author><name sortKey="Alami Chentoufi, Aziz" sort="Alami Chentoufi, Aziz" uniqKey="Alami Chentoufi A" first="Aziz" last="Alami Chentoufi">Aziz Alami Chentoufi</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1><s2>Irvine, California 92697-4375</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Binder, Nicholas R" sort="Binder, Nicholas R" uniqKey="Binder N" first="Nicholas R." last="Binder">Nicholas R. Binder</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1><s2>Irvine, California 92697-4375</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Berka, Noureddine" sort="Berka, Noureddine" uniqKey="Berka N" first="Noureddine" last="Berka">Noureddine Berka</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Tissue Typing Laboratory</s1><s2>Calgary, Alberta T2L2K8</s2><s3>CAN</s3><sZ>3 aut.</sZ></inist:fA14><country>Canada</country></affiliation></author><author><name sortKey="Durand, Guillaume" sort="Durand, Guillaume" uniqKey="Durand G" first="Guillaume" last="Durand">Guillaume Durand</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>CEA, iBiTecS, Service d'Ingenierie Moléculaire des Protéines (SIMOPRO)</s1><s2>Gif Sur Yvette 91191</s2><s3>FRA</s3><sZ>4 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>France</country></affiliation></author><author><name sortKey="Nguyen, Alex" sort="Nguyen, Alex" uniqKey="Nguyen A" first="Alex" last="Nguyen">Alex Nguyen</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1><s2>Irvine, California 92697-4375</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Bettahi, Ilham" sort="Bettahi, Ilham" uniqKey="Bettahi I" first="Ilham" last="Bettahi">Ilham Bettahi</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1><s2>Irvine, California 92697-4375</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Maillere, Bernard" sort="Maillere, Bernard" uniqKey="Maillere B" first="Bernard" last="Maillere">Bernard Maillere</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>CEA, iBiTecS, Service d'Ingenierie Moléculaire des Protéines (SIMOPRO)</s1><s2>Gif Sur Yvette 91191</s2><s3>FRA</s3><sZ>4 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>France</country></affiliation></author><author><name sortKey="Benmohamed, Lbachir" sort="Benmohamed, Lbachir" uniqKey="Benmohamed L" first="Lbachir" last="Benmohamed">Lbachir Benmohamed</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1><s2>Irvine, California 92697-4375</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Center for Immunology, University of California Irvine</s1><s2>Irvine, California 92697-1450</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author></analytic><series><title level="j" type="main">Journal of virology</title><title level="j" type="abbreviated">J. virol.</title><idno type="ISSN">0022-538X</idno><imprint><date when="2008">2008</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Journal of virology</title><title level="j" type="abbreviated">J. virol.</title><idno type="ISSN">0022-538X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antigenic determinant</term><term>Asymptomatic</term><term>Cytotoxic T lymphocyte</term><term>Glycoprotein</term><term>Herpesvirus hominis</term><term>Human</term><term>T-Lymphocyte</term><term>Virology</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Homme</term><term>Herpesvirus hominis</term><term>Asymptomatique</term><term>Lymphocyte T</term><term>Lymphocyte T cytotoxique</term><term>Déterminant antigénique</term><term>Glycoprotéine</term><term>Virologie</term><term>Antigène CD4</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The identification of "asymptomatic" (i.e., protective) epitopes recognized by T cells from herpes simplex virus (HSV)-seropositive healthy individuals is a prerequisite for an effective vaccine. Using the PepScan epitope mapping strategy, a library of 179 potential peptide epitopes (15-mers overlapping by 10 amino acids) was identified from HSV type 1 (HSV-1) glycoprotein B (gB), an antigen that induces protective immunity in both animal models and humans. Eighteen groups (G1 to G18) of 10 adjacent peptides each were first screened for T-cell antigenicity in 38 HSV-1-seropositive but HSV-2-seronegative individuals. Individual peptides within the two immunodominant groups (i.e., G4 and G14) were further screened with T cells from HLA-DR-genotyped and clinically defined symptomatic (n = 10) and asymptomatic (n = 10) HSV-1-seropositive healthy individuals. Peptides gB<sub>161-175</sub> and gB<sub>166-180</sub> within G4 and gB<sub>661-675</sub> within G14 recalled the strongest HLA-DR-dependent CD4<sup>+</sup> T-cell proliferation and gamma interferon production. gB<sub>166-180,</sub> gB<sub>661-675</sub>, and gB<sub>666-680</sub> elicited ex vivo CD4<sup>+</sup> cytotoxic T cells (CTLs) that lysed autologous HSV-1- and vaccinia virus (expressing gB)-infected lymphoblastoid cell lines. Interestingly, gB<sub>166-180</sub> and gB<sub>666-680</sub> peptide epitopes were strongly recognized by CD4<sup>+</sup> T cells from 10 of 10 asymptomatic patients but not by CD4<sup>+</sup> T cells from 10 of 10 symptomatic patients (P < 0.0001; analysis of variance posttest). Inversely, CD4<sup>+</sup> T cells from symptomatic patients preferentially recognized gB<sub>661-675</sub> (P < 0.0001). Thus, we identified three previously unrecognized CD4<sup>+</sup> CTL peptide epitopes in HSV-1 gB. Among these, gB<sub>166-180</sub> and gB<sub>666-680</sub> appear to be "asymptomatic" peptide epitopes and therefore should be considered in the design of future herpes vaccines.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0022-538X</s0></fA01><fA03 i2="1"><s0>J. virol.</s0></fA03><fA05><s2>82</s2></fA05><fA06><s2>23</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B</s1></fA08><fA11 i1="01" i2="1"><s1>ALAMI CHENTOUFI (Aziz)</s1></fA11><fA11 i1="02" i2="1"><s1>BINDER (Nicholas R.)</s1></fA11><fA11 i1="03" i2="1"><s1>BERKA (Noureddine)</s1></fA11><fA11 i1="04" i2="1"><s1>DURAND (Guillaume)</s1></fA11><fA11 i1="05" i2="1"><s1>NGUYEN (Alex)</s1></fA11><fA11 i1="06" i2="1"><s1>BETTAHI (Ilham)</s1></fA11><fA11 i1="07" i2="1"><s1>MAILLERE (Bernard)</s1></fA11><fA11 i1="08" i2="1"><s1>BENMOHAMED (Lbachir)</s1></fA11><fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1><s2>Irvine, California 92697-4375</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ><sZ>8 aut.</sZ></fA14><fA14 i1="02"><s1>Tissue Typing Laboratory</s1><s2>Calgary, Alberta T2L2K8</s2><s3>CAN</s3><sZ>3 aut.</sZ></fA14><fA14 i1="03"><s1>CEA, iBiTecS, Service d'Ingenierie Moléculaire des Protéines (SIMOPRO)</s1><s2>Gif Sur Yvette 91191</s2><s3>FRA</s3><sZ>4 aut.</sZ><sZ>7 aut.</sZ></fA14><fA14 i1="04"><s1>Center for Immunology, University of California Irvine</s1><s2>Irvine, California 92697-1450</s2><s3>USA</s3><sZ>8 aut.</sZ></fA14><fA20><s1>11792-11802</s1></fA20><fA21><s1>2008</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>13592</s2><s5>354000184531680310</s5></fA43><fA44><s0>0000</s0><s1>© 2009 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>80 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>09-0013229</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Journal of virology</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>The identification of "asymptomatic" (i.e., protective) epitopes recognized by T cells from herpes simplex virus (HSV)-seropositive healthy individuals is a prerequisite for an effective vaccine. Using the PepScan epitope mapping strategy, a library of 179 potential peptide epitopes (15-mers overlapping by 10 amino acids) was identified from HSV type 1 (HSV-1) glycoprotein B (gB), an antigen that induces protective immunity in both animal models and humans. Eighteen groups (G1 to G18) of 10 adjacent peptides each were first screened for T-cell antigenicity in 38 HSV-1-seropositive but HSV-2-seronegative individuals. Individual peptides within the two immunodominant groups (i.e., G4 and G14) were further screened with T cells from HLA-DR-genotyped and clinically defined symptomatic (n = 10) and asymptomatic (n = 10) HSV-1-seropositive healthy individuals. Peptides gB<sub>161-175</sub> and gB<sub>166-180</sub> within G4 and gB<sub>661-675</sub> within G14 recalled the strongest HLA-DR-dependent CD4<sup>+</sup> T-cell proliferation and gamma interferon production. gB<sub>166-180,</sub> gB<sub>661-675</sub>, and gB<sub>666-680</sub> elicited ex vivo CD4<sup>+</sup> cytotoxic T cells (CTLs) that lysed autologous HSV-1- and vaccinia virus (expressing gB)-infected lymphoblastoid cell lines. Interestingly, gB<sub>166-180</sub> and gB<sub>666-680</sub> peptide epitopes were strongly recognized by CD4<sup>+</sup> T cells from 10 of 10 asymptomatic patients but not by CD4<sup>+</sup> T cells from 10 of 10 symptomatic patients (P < 0.0001; analysis of variance posttest). Inversely, CD4<sup>+</sup> T cells from symptomatic patients preferentially recognized gB<sub>661-675</sub> (P < 0.0001). Thus, we identified three previously unrecognized CD4<sup>+</sup> CTL peptide epitopes in HSV-1 gB. Among these, gB<sub>166-180</sub> and gB<sub>666-680</sub> appear to be "asymptomatic" peptide epitopes and therefore should be considered in the design of future herpes vaccines.</s0></fC01><fC02 i1="01" i2="X"><s0>002A05C10</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Homme</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Human</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Hombre</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Herpesvirus hominis</s0><s2>NW</s2><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Herpesvirus hominis</s0><s2>NW</s2><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Herpesvirus hominis</s0><s2>NW</s2><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Asymptomatique</s0><s5>05</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Asymptomatic</s0><s5>05</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Asintomático</s0><s5>05</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Lymphocyte T</s0><s5>06</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>T-Lymphocyte</s0><s5>06</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Linfocito T</s0><s5>06</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Lymphocyte T cytotoxique</s0><s5>07</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Cytotoxic T lymphocyte</s0><s5>07</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Linfocito T citotóxico</s0><s5>07</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Déterminant antigénique</s0><s5>08</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Antigenic determinant</s0><s5>08</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Determinante antigénico</s0><s5>08</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Glycoprotéine</s0><s5>09</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Glycoprotein</s0><s5>09</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Glicoproteína</s0><s5>09</s5></fC03><fC03 i1="08" i2="X" l="FRE"><s0>Virologie</s0><s5>10</s5></fC03><fC03 i1="08" i2="X" l="ENG"><s0>Virology</s0><s5>10</s5></fC03><fC03 i1="08" i2="X" l="SPA"><s0>Virología</s0><s5>10</s5></fC03><fC03 i1="09" i2="X" l="FRE"><s0>Antigène CD4</s0><s4>INC</s4><s5>79</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Alphaherpesvirinae</s0><s2>NW</s2></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Alphaherpesvirinae</s0><s2>NW</s2></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Alphaherpesvirinae</s0><s2>NW</s2></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Herpesviridae</s0><s2>NW</s2></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Herpesviridae</s0><s2>NW</s2></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Herpesviridae</s0><s2>NW</s2></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Virus</s0><s2>NW</s2></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Virus</s0><s2>NW</s2></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Virus</s0><s2>NW</s2></fC07><fN21><s1>007</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000025 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000025 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:09-0013229
|texte= Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B
}}
| This area was generated with Dilib version V0.6.33. |  |